Hematology-Oncology Clinics of North America

Papers
(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Autoimmune Hemolytic Anemia: An Old Disease with New Twists124
Managing First-Line Metastatic Renal Cell Carcinoma62
Conflict and Access to Health Care59
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia55
Insights into Renal Cell Carcinoma with Novel Imaging Approaches36
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia35
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis33
Treatment of High-Risk Gestational Trophoblastic Neoplasia32
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver30
Cancer of the Larynx and Hypopharynx30
Contributors29
Contents29
Benefits and Harms of Interception and Early Detection of Cancer28
Hematology/Oncology Clinics of North America27
Copyright26
Advances in Gastric Cancer Surgical Management23
Contributors23
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes23
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer22
Disparities in Breast Cancer Outcomes and How to Resolve Them22
Updates in the Management of Warm Autoimmune Hemolytic Anemia21
Future Directions for Gestational Trophoblastic Disease21
The Evolving Landscape of Drug Therapies for Sickle Cell Disease21
Factor XIII Deficiency19
Advances in Immunotherapy in Esophagogastric Cancer19
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas18
Inherited Platelet Disorders16
Foreword14
Contents14
Advances in Surgical Techniques for Lung Cancer14
Advances in Systemic Therapy in Pancreatic Cancer14
Liposarcoma14
Emerging Therapies in β-Thalassemia14
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma14
The Need for Translational Epidemiology in Beta Thalassemia Syndromes14
Adult Evans' Syndrome13
Histiocytic Disorders in Pediatric and Adult Patients13
Genes as Medicine13
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children13
Clinical Vignettes Part I13
Forthcoming Issues13
Genomic Alterations in Langerhans Cell Histiocytosis13
Copyright13
Hereditary Renal Cell Carcinoma Syndromes12
Skin Cancer Precursors12
Red Cell Antigens and Antibodies12
Patient-Reported Outcomes in Radiation Oncology11
Gestational Trophoblastic Neoplasia11
Malignancies of the Upper Gastrointestinal Tract11
Heavy Ion Particle Therapy in Modern Day Radiation Oncology11
Contents11
New Developments in Myeloma11
Copyright11
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities11
Evaluation and Management of Bing–Neel Syndrome11
Advances in the Surgical Management of Esophageal Cancer10
High-Risk Non-Melanoma Skin Cancers10
Local Control in Soft Tissue Sarcomas10
Bispecific Antibodies in the Treatment of Multiple Myeloma10
Contents9
Evolution of Gene Therapy, Historical Perspective9
Forthcoming Issues9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy9
Copyright9
Melanoma Brain Metastasis8
Contents8
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer8
Breast Cancer in India8
Disparities and Inequities Among Patients with Central Nervous System Tumor8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms8
Radiation-Induced Tissue Regeneration8
Copyright7
Breast Cancer and Lifestyle Factors7
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma7
FLASH Radiotherapy6
Hemophilia A/B6
Disorders of Fibrinogen and Fibrinolysis6
Impact of Clonal Heterogeneity in Multiple Myeloma6
Education and Training Models for Remote Learning6
Ductal Carcinoma In Situ6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors6
Targeted Therapy Innovations for Melanoma6
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers6
Clinical Complications and Their Management6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma6
Early Detection of Precursor Diseases of Multiple Myeloma5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing5
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis5
Immune-Pathogenesis of Myeloma5
Pathogenic Mechanisms in Thalassemia II5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy5
Merkel Cell Carcinoma5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia5
Contributors5
Approach to High-Risk Multiple Myeloma5
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies5
Copyright5
Sarcomas5
Immunotherapy-associated Autoimmune Hemolytic Anemia5
Pathogenic Mechanisms in Thalassemia I5
Genetics and Genomics of Gestational Trophoblastic Disease5
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia4
Remembering the Contributions of Professor David J. Weatherall4
Contributors4
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia4
Smoldering Multiple Myeloma4
Contributors4
Complications of Autoimmune Hemolytic Anemia4
Renal Cell Cancer4
Local Therapies in Advanced Colorectal Cancer4
Forthcoming Issues4
Debate4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)4
Role of Radiation in Treatment of Renal Cell Carcinoma4
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia4
Contents4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings4
Regulatory Aspects of Gene Therapy4
Cutaneous T-cell Lymphoma4
Waldenström Macroglobulinemia4
Cancer of the Paranasal Sinuses4
0.092452049255371